Toru Naganuma

Showing 1-9 of 9 articles

Silent Valsalva thrombus between the native Valsalva and balloon-expandable transcatheter heart valve: multicentre Japanese registry analysis

Tsunaki T, Yamamoto M, Shimura T, Kagase A, Naganuma T, Higashimori A, Araki M, Yamanaka F, Mizutani K, Watanabe Y, Otsuka T, Yanagisawa R, Hayashida K

November 15, 2019 | 10.4244/EIJ-D-19-00370

Coronary interventions

Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP score

Ortega-Paz L, Capodanno D, Gori T, Nef H, Latib A, Caramanno G, Di Mario C, Naber C, Lesiak M, Capranzano P, Wiebe J, Mehilli J, Araszkiewicz A, Pyxaras S, Mattesini A, Geraci S, Naganuma T, Colombo A, Münzel T, Sabaté M, Tamburino C, Brugaletta S

April 20, 2017 | 10.4244/EIJ-D-16-00974

Coronary interventions

Clinical outcomes of a real-world cohort following bioresorbable vascular scaffold implantation utilising an optimised implantation strategy

Tanaka A, Latib A, Kawamoto H, Jabbour R, Sato K, Miyazaki T, Naganuma T, Mangieri A, Pagnesi M, Montalto C, Chieffo A, Carlino M, Montorfano M, Colombo A

February 20, 2017 | 10.4244/EIJ-D-16-00247

Coronary interventions

Procedural outcomes of patients with calcified lesions treated with bioresorbable vascular scaffolds

Panoulas V, Miyazaki T, Sato K, Naganuma T, Sticchi A, Kawamoto H, Figini F, Chieffo A, Carlino M, Montorfano M, Latib A, Colombo A

March 18, 2016 | 10.4244/EIJY15M03_11

Coronary interventions

Drug-eluting balloon versus second-generation drug-eluting stent for the treatment of restenotic lesions involving coronary bifurcations

Naganuma T, Latib A, Costopoulos C, Oreglia J, Testa L, De Marco F, Candreva A, Chieffo A, Naim C, Montorfano M, Bedogni F, Colombo A

January 20, 2016 | 10.4244/EIJY14M11_01

How should I treat multiple coronary aneurysms with severe stenoses?

Warisawa T, Naganuma T, Nakamura S

November 20, 2015 | 10.4244/EIJV11I7A171

Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry

Capodanno D, Gori T, Nef H, Latib A, Mehilli J, Lesiak M, Caramanno G, Naber C, Di Mario C, Colombo A, Capranzano P, Wiebe J, Araszkiewicz A, Geraci S, Pyxaras S, Mattesini A, Naganuma T, Münzel T, Tamburino C

February 20, 2015 | 10.4244/EIJY14M07_11

Percutaneous intervention of calcific coronary lesions

Costopoulos C, Naganuma T, Colombo A

March 3, 2014

Tools and Techniques Clinical: Percutaneous intervention of calcific coronary lesions

Costopoulos C, Naganuma T, Colombo A

January 20, 2014 | 10.4244/EIJV9I9A188

Latest news

NEW ISSUE

Lipid-lowering therapy and PCI; thin vs thick stents; mini focus on STEMI; and more…

April 20, 2021

NEW

Outcomes of transcatheter tricuspid valve intervention by right ventricular function

Florian Schlotter et al.

May 5, 2021

EDITORIAL

How to eliminate mitral regurgitation definitively: the eternal dilemma?

Thomas Modine et al.

May 5, 2021

NEWS

EBC 15th consensus document - Watch the Chat!

Relive the 2nd edition

April 21, 2021

PCR Trials

New update: EXAMINATION 10 years, BIONYX 2 years, SAFE A, MASH and more

(Thanks to the support of Biotronik)

April 13, 2021

EDITORIAL

To be better among the best: a difficult task

Antonio Colombo et al.

April 26, 2021

JAA

New JAA's: Calcification of PAD by OFDI and IVUS, Simultaneous PTVR reversing right-left shunts following PMVR?...